Wednesday, August 26, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· April 14, 2026

Crypto News: ByBit Is Now Letting Traders Use Bitcoin and Ethereum to Trade Stocks Like Apple and BlackRock’s IBIT

View original at finance.yahoo.com
Crypto News: ByBit Is Now Letting Traders Use Bitcoin and Ethereum to Trade Stocks Like Apple and BlackRock’s IBIT Quick Read ByBit launched 44 new stock CFDs on April 13, including Apple, Amazon, BlackRock’s IBIT Bitcoin ETF, Manchester United, Phillips 66, and sector ETFs covering energy, lithium, and uranium…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Crypto-backed stock trading could tighten Bitcoin supply further if the model spreads

    60% confidence
  • The platform now offers over 130 stock CFDs in total

    60% confidence
  • This turns Bitcoin and Ethereum from assets you hold and hope go up into assets you actively use

    60% confidence
  • Bitcoin exchange reserves have dropped to around 2.3 million BTC in 2026, a seven-year low

    60% confidence

Data points we hold from this source

Bitcoin · collateral value ratio98 percent
Bitcoin · exchange reserves2.3 million_btc
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com
Crypto News: ByBit Is Now Letting Traders Use Bitcoin and Ethereum to Trade Stocks Like Apple and BlackRock’s IBIT — Source | Via News | ViaNews Market